Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New MR imaging contrast agents.

J P Earls1, D A Bluemke

  • 1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jearls@rad.jhu.edu

Magnetic Resonance Imaging Clinics of North America
|June 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photon-Counting CT of the Brain: In Vivo Human Results and Image-Quality Assessment.

AJNR. American journal of neuroradiology·2017
Same author

CT calcium scoring. History, current status and outlook.

Diagnostic and interventional imaging·2016
Same author

Three-dimensional imaging: Past, present and future.

Diagnostic and interventional imaging·2016
Same author

Visceral adiposity and left ventricular remodeling: The Multi-Ethnic Study of Atherosclerosis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
Same author

Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Molecular imaging and biology·2015
Same author

Differentiation of myocardial scar from potential pitfalls and artefacts in delayed enhancement MRI.

The British journal of radiology·2012

New magnetic resonance (MR) contrast agents offer unique advantages over traditional imaging. Understanding their specific properties, clinical uses, and limitations is crucial for effective application in various medical fields.

Area of Science:

  • Medical Imaging
  • Radiology
  • Pharmacology

Background:

  • Numerous novel magnetic resonance (MR) contrast agents are in development or clinical use.
  • These agents target specific receptors for accumulation in the reticuloendothelial system, hepatobiliary system, or blood pool.
  • They present distinct advantages compared to unenhanced and gadolinium chelate-enhanced MR imaging.

Purpose of the Study:

  • To review the development, evaluation, and clinical applications of new MR contrast agents.
  • To highlight the unique properties, indications, and limitations of these novel agents.

Main Methods:

  • Review of current literature and clinical trial data.
  • Analysis of agent properties, targeting mechanisms, and clinical performance.

Related Experiment Videos

  • Comparison with existing MR imaging techniques.

    • Main Results:

    • Ferumoxides, Mn-DPDP, AMI-227, SHU-555A, Gd-EOB/DTPA, Gd-BOPTA, and MS-325 are among the agents discussed.
    • Each agent demonstrates specific targeting and accumulation characteristics.
    • Advantages over conventional MR imaging are noted for various applications.

    Conclusions:

    • New MR contrast agents offer improved diagnostic capabilities.
    • Understanding agent-specific properties and limitations is essential for optimal clinical use.
    • These agents represent a significant advancement in MR imaging technology.